BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8448641)

  • 1. Cyclosporin A nephropathy in patients with rheumatoid arthritis.
    Ludwin D; Alexopoulou I
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():60-4. PubMed ID: 8448641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():65-71. PubMed ID: 8448642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study.
    Assan R; Timsit J; Feutren G; Bougnères P; Czernichow P; Hannedouche T; Boitard C; Noel LH; Mihatsch MJ; Bach JF
    Clin Nephrol; 1994 Jan; 41(1):41-9. PubMed ID: 8137568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
    Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
    J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.
    van den Borne BE; Landewé RB; Goei The HS; Rietveld JH; Zwinderman AH; Bruyn GA; Breedveld FC; Dijkmans BA
    J Rheumatol; 1998 Aug; 25(8):1493-8. PubMed ID: 9712089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cyclosporin-induced nephropathy.
    Takahara S; Ota K; Takahashi K; Uchida K; Morozumi K; Wang JD; Kyo M;
    Clin Nephrol; 2001 Jan; 55(1):69-72. PubMed ID: 11200870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
    Tugwell P; Ludwin D; Gent M; Roberts R; Bensen W; Grace E; Baker P
    J Rheumatol; 1997 Jun; 24(6):1122-5. PubMed ID: 9195520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies in rheumatoid arthritis patients treated with cyclosporin A.
    Arellano F; Krupp P
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():72-5. PubMed ID: 8448643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies.
    Mihatsch MJ; Antonovych T; Bohman SO; Habib R; Helmchen U; Noel LH; Olsen S; Sibley RK; Kemény E; Feutren G
    Clin Nephrol; 1994 Jan; 41(1):23-32. PubMed ID: 8137566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis.
    Sund S; Førre O; Berg KJ; Kvien TK; Hovig T
    Clin Nephrol; 1994 Jan; 41(1):33-40. PubMed ID: 8137567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.
    Kovarik JM; Kurki P; Mueller E; Guerret M; Markert E; Alten R; Zeidler H; Genth-Stolzenburg S
    J Rheumatol; 1996 Dec; 23(12):2033-8. PubMed ID: 8970037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
    Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissilä M; Keystone EC; Kraag GR; Bjørneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM
    J Rheumatol; 1999 Mar; 26(3):556-62. PubMed ID: 10090162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cyclosporin A in rheumatoid arthritis: worldwide experience.
    Dougados M; Torley H
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():57-9. PubMed ID: 8448640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis.
    Altman RD; Perez GO; Sfakianakis GN
    Am J Med; 1992 Oct; 93(4):396-402. PubMed ID: 1415303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases].
    Krüger K
    Z Rheumatol; 1995; 54(2):89-95. PubMed ID: 7793161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international consensus report: the use of cyclosporin A in rheumatoid arthritis.
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():1-3. PubMed ID: 8448629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
    Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
    J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy.
    Ferraccioli G; Falleti E; De Vita S; Di Poi E; Damato R; Casatta L; Salaffi F
    J Rheumatol; 1998 Oct; 25(10):1874-9. PubMed ID: 9779838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.